<!doctype html><html lang=en-us dir=ltr><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=description content="An interesting update in the progress of the CRISPR/Broad Institute appeal (T0844/18) has reached this Kat‚Äôs fluffy ears. As previously reported on IPKat, oral proceedings are scheduled for 13-17 January 2020. The Board of Appeal (BA), 3.3.08, has now issued a communication summarising the issues that will be discussed in the hearing. It seems that the 4.5 day hearing will be almost entirely devoted to consideration of whether the EPO‚Äôs long-standing approach to priority, particularly the ‚Äúsame applicant test‚Äù, should be altered."><title>BREAKING: Board of Appeal provides some initial thoughts on the Broad Institute‚Äôs CRISPR appeal (T0844/18)</title><link rel=canonical href=https://Nexus-Security.github.io/posts/2016-09-09-breaking-board-of-appeal-provides-some/><link rel=stylesheet href=/scss/style.min.450926226e724574a6b936335ea06111f8aeb253d932c86cb2cc807341cd2889.css><meta property="og:title" content="BREAKING: Board of Appeal provides some initial thoughts on the Broad Institute‚Äôs CRISPR appeal (T0844/18)"><meta property="og:description" content="An interesting update in the progress of the CRISPR/Broad Institute appeal (T0844/18) has reached this Kat‚Äôs fluffy ears. As previously reported on IPKat, oral proceedings are scheduled for 13-17 January 2020. The Board of Appeal (BA), 3.3.08, has now issued a communication summarising the issues that will be discussed in the hearing. It seems that the 4.5 day hearing will be almost entirely devoted to consideration of whether the EPO‚Äôs long-standing approach to priority, particularly the ‚Äúsame applicant test‚Äù, should be altered."><meta property="og:url" content="https://Nexus-Security.github.io/posts/2016-09-09-breaking-board-of-appeal-provides-some/"><meta property="og:site_name" content="ZYChimne"><meta property="og:type" content="article"><meta property="article:section" content="Posts"><meta property="article:published_time" content="2019-10-30T18:34:00+01:00"><meta property="article:modified_time" content="2019-10-30T18:34:00+01:00"><meta name=twitter:title content="BREAKING: Board of Appeal provides some initial thoughts on the Broad Institute‚Äôs CRISPR appeal (T0844/18)"><meta name=twitter:description content="An interesting update in the progress of the CRISPR/Broad Institute appeal (T0844/18) has reached this Kat‚Äôs fluffy ears. As previously reported on IPKat, oral proceedings are scheduled for 13-17 January 2020. The Board of Appeal (BA), 3.3.08, has now issued a communication summarising the issues that will be discussed in the hearing. It seems that the 4.5 day hearing will be almost entirely devoted to consideration of whether the EPO‚Äôs long-standing approach to priority, particularly the ‚Äúsame applicant test‚Äù, should be altered."></head><body class=article-page><script>(function(){const e="StackColorScheme";localStorage.getItem(e)||localStorage.setItem(e,"auto")})()</script><script>(function(){const t="StackColorScheme",e=localStorage.getItem(t),n=window.matchMedia("(prefers-color-scheme: dark)").matches===!0;e=="dark"||e==="auto"&&n?document.documentElement.dataset.scheme="dark":document.documentElement.dataset.scheme="light"})()</script><div class="container main-container flex on-phone--column extended"><aside class="sidebar left-sidebar sticky"><button class="hamburger hamburger--spin" type=button id=toggle-menu aria-label="Toggle Menu">
<span class=hamburger-box><span class=hamburger-inner></span></span></button><header><figure class=site-avatar><a href=/><img src=/img/avatar_hu8b78332b6420dc9affabe23720d11e63_1937019_300x0_resize_q75_box.jpg width=300 height=300 class=site-logo loading=lazy alt=Avatar></a>
<span class=emoji>üçá</span></figure><div class=site-meta><h1 class=site-name><a href=/>ZYChimne</a></h1><h2 class=site-description>Computer Science, Wuhan University</h2></div></header><ol class=social-menu><li><a href=https://github.com/ZYChimne target=_blank title=GitHub><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-brand-github" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z" fill="none"/><path d="M9 19c-4.3 1.4-4.3-2.5-6-3m12 5v-3.5c0-1 .1-1.4-.5-2 2.8-.3 5.5-1.4 5.5-6a4.6 4.6.0 00-1.3-3.2 4.2 4.2.0 00-.1-3.2s-1.1-.3-3.5 1.3a12.3 12.3.0 00-6.2.0C6.5 2.8 5.4 3.1 5.4 3.1a4.2 4.2.0 00-.1 3.2A4.6 4.6.0 004 9.5c0 4.6 2.7 5.7 5.5 6-.6.6-.6 1.2-.5 2V21"/></svg></a></li><li><a href=https://twitter.com/ZChimne target=_blank title=Twitter><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-brand-twitter" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z" fill="none"/><path d="M22 4.01c-1 .49-1.98.689-3 .99-1.121-1.265-2.783-1.335-4.38-.737S11.977 6.323 12 8v1c-3.245.083-6.135-1.395-8-4 0 0-4.182 7.433 4 11-1.872 1.247-3.739 2.088-6 2 3.308 1.803 6.913 2.423 10.034 1.517 3.58-1.04 6.522-3.723 7.651-7.742a13.84 13.84.0 00.497-3.753C20.18 7.773 21.692 5.25 22 4.009z"/></svg></a></li></ol><ol class=menu id=main-menu><li><a href=/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-home" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><polyline points="5 12 3 12 12 3 21 12 19 12"/><path d="M5 12v7a2 2 0 002 2h10a2 2 0 002-2v-7"/><path d="M9 21v-6a2 2 0 012-2h2a2 2 0 012 2v6"/></svg><span>Home</span></a></li><li><a href=/about-me/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-user" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="7" r="4"/><path d="M6 21v-2a4 4 0 014-4h4a4 4 0 014 4v2"/></svg><span>About Me</span></a></li><div class=menu-bottom-section><li id=dark-mode-toggle><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-toggle-left" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="8" cy="12" r="2"/><rect x="2" y="6" width="20" height="12" rx="6"/></svg><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-toggle-right" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="16" cy="12" r="2"/><rect x="2" y="6" width="20" height="12" rx="6"/></svg><span>Dark Mode</span></li></div></ol></aside><main class="main full-width"><article class=main-article><header class=article-header><div class=article-details><div class=article-title-wrapper><h2 class=article-title><a href=/posts/2016-09-09-breaking-board-of-appeal-provides-some/>BREAKING: Board of Appeal provides some initial thoughts on the Broad Institute‚Äôs CRISPR appeal (T0844/18)</a></h2></div><footer class=article-time><div><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-calendar-time" width="56" height="56" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><path d="M11.795 21H5a2 2 0 01-2-2V7a2 2 0 012-2h12a2 2 0 012 2v4"/><circle cx="18" cy="18" r="4"/><path d="M15 3v4"/><path d="M7 3v4"/><path d="M3 11h16"/><path d="M18 16.496V18l1 1"/></svg><time class=article-time--published>Oct 30, 2019</time></div><div><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-clock" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="12" r="9"/><polyline points="12 7 12 12 15 15"/></svg><time class=article-time--reading>4 minute read</time></div></footer></div></header><section class=article-content><p><strong>An interesting update in the progress of the CRISPR/Broad Institute appeal (T0844/18) has reached this Kat‚Äôs fluffy ears. As</strong> <a class=link href="http://ipkitten.blogspot.com/2019/03/should-everyone-else-change-or-just.html?_sm_au_=iVV1W7F0sStT02mVpGsWvKttvN1NG" target=_blank rel=noopener><strong>previously reported</strong></a> <strong>on IPKat, oral proceedings are scheduled for 13-17 January 2020. The Board of Appeal (BA), 3.3.08, has now issued a communication summarising the issues that will be discussed in the hearing. It seems that the 4.5 day hearing will be almost entirely devoted to consideration of whether the EPO‚Äôs long-standing approach to priority, particularly the ‚Äúsame applicant test‚Äù, should be altered. Many thanks to an anonymous Katfriend for sending the communication to IPKat.</strong></p><p>**Background¬†**</p><p>T0844/18 is an appeal from the opposition division (OD) decision to revoke the Broad‚Äôs Institute‚Äôs CRISPR/Cas-9 patent, on the grounds of lack of novelty in view of an invalid priority claim (IPKat post <a class=link href="http://ipkitten.blogspot.com/2018/01/epo-revokes-crispr-patent-clear-cut.html?_sm_au_=iVV1W7F0sStT02mVpGsWvKttvN1NG" target=_blank rel=noopener><strong>here</strong></a>). The OD decision was in line with the large body of EPO case law on priority. The case law provides that the right to claim priority from an earlier application according to <a class=link href=https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar87.html target=_blank rel=noopener><strong>Article 87 EPC</strong></a> is afforded to the applicant of the earlier application and to no other party (i.e the applicant(s) must be the same). The Broad&rsquo;s CRISPR European patent (<a class=link href="https://register.epo.org/application?number=EP13818570" target=_blank rel=noopener><strong>EP2771468</strong></a>) was based on a PCT filing (<a class=link href="https://worldwide.espacenet.com/publicationDetails/biblio?II=225&ND=3&adjacent=true&locale=en_EP&FT=D&date=20141224&CC=WO&NR=2014204729A1&KC=A1" target=_blank rel=noopener><strong>WO 2014204729</strong></a>) claiming priority from a number of US provisional applications. One of the US provisionals named an inventor-applicant who was not named on the PCT application. The EP patent was thus revoked in view of an invalid priority claim.</p><p>The importance of the case (and the significant commercial importance of CRISPR), is reflected by the Broad Institute‚Äôs ninety-four page grounds of appeal, with supporting declarations from such eminent persons as Lord Neuberger and Lord Hoffman (IPKat post <a class=link href="http://ipkitten.blogspot.com/2019/03/should-everyone-else-change-or-just.html?_sm_au_=iVV1W7F0sStT02mVpGsWvKttvN1NG" target=_blank rel=noopener><strong>here</strong></a>). Equally long responses have been submitted by the numerous opponents.</p><p><strong>Preliminary thoughts from the Board of Appeal</strong></p><p>From the Communication, it is clear that majority of the 4.5 day hearing will be taken up with discussion of the substantive issue of the validity of the Broad‚Äôs priority claim.¬† The issue in question is succinctly summarised by the BA:</p><p>&ldquo;<strong>A and B are applicants for the priority application. A alone is the applicant of the subsequent application. Is the priority claim valid even without any assignment of priority right from B to A</strong></p><p><strong>The appellants say that the answer is ‚Äòyes‚Äô and the respondents that it is ‚Äòno‚Äô</strong>".¬†</p><p>The BA then provides a preliminary view of some of the points of contention among the parties.</p><p>The BA first notes that current case law favours the opponents of the patent. Regarding the linguistic arguments relating the meaning of ‚Äúany person‚Äù in Article 87 EPC, the BA ‚Äúis of the view that the term ‚Äòany person‚Äô is ambiguous, rending attempts to elucidate the meaning of these provisions upon a purely linguistic basis difficult and most unlikely to succeed‚Äù.</p><p><a class=link href=https://1.bp.blogspot.com/-K63olZChe-M/XbnJLH23UJI/AAAAAAAAJT4/KvZ7B3bYOmYRuH1w0CTC4QcOMhM6y4xZwCNcBGAsYHQ/s1600/audience-many-cat-cats-island.jpg target=_blank rel=noopener><img src=https://1.bp.blogspot.com/-K63olZChe-M/XbnJLH23UJI/AAAAAAAAJT4/KvZ7B3bYOmYRuH1w0CTC4QcOMhM6y4xZwCNcBGAsYHQ/s320/audience-many-cat-cats-island.jpg loading=lazy></a></p><p><em>A packed room is expected at oral proceedings</em></p><p>On the relevance of national law (as argued for by the Broad), the BA notes that the EPC provides a complete system for determining whether a priority right has been correctly claimed, and that the issue may be resolved by the EPO without reference to national law. The BA also notes that it cannot find any merits in the references by the parties to national law as regards some aspects of real property. Perhaps unsurprisingly, the BA‚Äôs initial thoughts therefore do not appear to be favourable to the Broad.</p><p>The BA concludes that the outcome of the case will turn upon the pros and cons of altering the EPO‚Äôs practice on how the <a class=link href=https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar87.html target=_blank rel=noopener><strong>Article 87 EPC</strong></a> is interpreted. As neatly summarised by the BA, according to the Opponents, factors possibly speaking for maintaining the current EPO practice are:</p><ul><li>‚ÄúThe practice is long standing.</li><li>It may protect joint applicants against sharp practice by a sub-group of the joint applicants.</li><li>The situation of the patentees in the present case could have been avoided if they had shown sufficient foresight.</li><li>There is a risk of multiple subsequent applications.</li><li>There could be other possible negative consequences of changing this practice.‚Äù</li></ul><p>The BA also summarises some factors possibly in favour of changing the present practice, as argued for by the Broad Institute:</p><ul><li>‚ÄúThe joint applicant for the priority application who is not mentioned in the subsequent application would be in a better position: it would at least have the possibility of asserting its rights in any patent resulting from the priority application; the present practice means that loss of priority may be followed by loss of the patent.</li><li>The appellants‚Äô approach is more in line with the aim of the <a class=link href="https://www.wipo.int/treaties/en/text.jsp?file_id=288514#P83_6610" target=_blank rel=noopener><strong>Paris Convention</strong></a>, that of facilitating international patenting as it relaxes the required formalities whilst safe-guarding those elements necessary for recognising a priority right under <a class=link href=https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar87.html target=_blank rel=noopener><strong>Article 87(1) EPC</strong></a>‚Äù</li></ul><p>The BA concludes that ‚Äú[i]t will probably be necessary to weigh up, amongst other considerations, the above factors in order to reach a decision‚Äù.</p><p>A large audience of interested parties is expected in Munich in early January. The hearing will be held in room 128 of the <a class=link href=https://www.epo.org/service-support/contact-us/munich/isar.html target=_blank rel=noopener><strong>Isar Building</strong></a>.</p><p>Stay tuned to IPKat for further updates!</p><p>[Update: the communication has now been published on the register, <a class=link href="https://register.epo.org/application?documentId=E3Z2HAR19821DSU&number=EP13818570&lng=en&npl=false" target=_blank rel=noopener><strong>here</strong></a>]</p></section><footer class=article-footer><section class=article-copyright><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-copyright" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="12" r="9"/><path d="M14.5 9a3.5 4 0 100 6"/></svg><span>Licensed under CC BY-NC-SA 4.0</span></section></footer></article><footer class=site-footer><section class=copyright>&copy;
2020 -
2022 ZYChimne</section><section class=powerby>Built with <a href=https://gohugo.io/ target=_blank rel=noopener>Hugo</a><br>Theme <b><a href=https://github.com/CaiJimmy/hugo-theme-stack target=_blank rel=noopener data-version=3.11.0>Stack</a></b> designed by <a href=https://jimmycai.com target=_blank rel=noopener>Jimmy</a></section></footer><div class=pswp tabindex=-1 role=dialog aria-hidden=true><div class=pswp__bg></div><div class=pswp__scroll-wrap><div class=pswp__container><div class=pswp__item></div><div class=pswp__item></div><div class=pswp__item></div></div><div class="pswp__ui pswp__ui--hidden"><div class=pswp__top-bar><div class=pswp__counter></div><button class="pswp__button pswp__button--close" title="Close (Esc)"></button>
<button class="pswp__button pswp__button--share" title=Share></button>
<button class="pswp__button pswp__button--fs" title="Toggle fullscreen"></button>
<button class="pswp__button pswp__button--zoom" title="Zoom in/out"></button><div class=pswp__preloader><div class=pswp__preloader__icn><div class=pswp__preloader__cut><div class=pswp__preloader__donut></div></div></div></div></div><div class="pswp__share-modal pswp__share-modal--hidden pswp__single-tap"><div class=pswp__share-tooltip></div></div><button class="pswp__button pswp__button--arrow--left" title="Previous (arrow left)"></button>
<button class="pswp__button pswp__button--arrow--right" title="Next (arrow right)"></button><div class=pswp__caption><div class=pswp__caption__center></div></div></div></div></div><script src=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe.min.js integrity="sha256-ePwmChbbvXbsO02lbM3HoHbSHTHFAeChekF1xKJdleo=" crossorigin=anonymous defer></script><script src=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe-ui-default.min.js integrity="sha256-UKkzOn/w1mBxRmLLGrSeyB4e1xbrp4xylgAWb3M42pU=" crossorigin=anonymous defer></script><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/default-skin/default-skin.css integrity="sha256-c0uckgykQ9v5k+IqViZOZKc47Jn7KQil4/MP3ySA3F8=" crossorigin=anonymous><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe.css integrity="sha256-SBLU4vv6CA6lHsZ1XyTdhyjJxCjPif/TRkjnsyGAGnE=" crossorigin=anonymous></main></div><script src=https://cdn.jsdelivr.net/npm/node-vibrant@3.1.5/dist/vibrant.min.js integrity="sha256-5NovOZc4iwiAWTYIFiIM7DxKUXKWvpVEuMEPLzcm5/g=" crossorigin=anonymous></script><script type=text/javascript src=/ts/main.js defer></script>
<script>(function(){const e=document.createElement("link");e.href="https://fonts.googleapis.com/css2?family=Lato:wght@300;400;700&display=swap",e.type="text/css",e.rel="stylesheet",document.head.appendChild(e)})()</script></body></html>